Fig. 2
From: Altered expression of ACOX2 in non-small cell lung cancer
Prognostic value of ACOX2 in NSCLC. The prognostic value of ACOX2 expression was assessed for overall survival (OS) using KM-Plotter [39] and by IHC on a patient TMA. Higher expression of the mRNA for ACOX2 was associated with better OS overall (A); which when stratified by tumour histology was limited to the LUAD subtype (B); whilst no difference in OS was observed for LUSC (C). In contrast no significant OS benefit was observed by IHC for high ACOX2 protein expression overall (D); or in LUAD (E); or LUSC (F). p < 0.05 was considered to be significant